Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Vitamin B 6 × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peripheral Nervous System Diseases 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 140 Docetaxel 132 Carboplatin 129 Bevacizumab 129 pembrolizumab 124 Radiotherapy 116 Gemcitabine 116 Cisplatin 115 Paclitaxel 114 Capecitabine 101 Rituximab 99 Fluorouracil 93 Oxaliplatin 88 Irinotecan 77 Nivolumab 76 Leucovorin 74 Doxorubicin 71 Dexamethasone 69 Pemetrexed 66 fludarabine 62 Etoposide 60 fludarabine phosphate 58 Bortezomib 57 Erlotinib Hydrochloride 55 Methotrexate 52 Cytarabine 52 Cetuximab 52 Trastuzumab 48 Sorafenib 43 Prednisone 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02795572 2019-07-05

CIPN

AHS Cancer Control Alberta

Phase 2 Terminated

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡